Publications for Cecilia Gunnarsson
Co-author map based on ISI articles 2007-

Publications mentioned in social media 2 times*

Keywords

women tumors tamoxifen survival prognostic patients hsd17b1 gene estrogen enzymes dehydrogenase cells cancer breast amplification 17ßhsd 17ß-hydroxysteroid 17ß-hydroxysteroid 17hsd2 17hsd

Journal Articles

Hans Olsson, Agneta Jansson, Birgitta Holmlund and Cecilia Gunnarsson
  Methods for evaluating HER2 status in breast cancer: comparison of IHC, FISH, and real-time PCR analysis of formalin-fixed paraffin-embedded tissue
 
Altmetric usage: 2

  Pathology and Laboratory Medicine International, 2013, 5, 31-37.
   Fulltext  PDF  

Tove Sivik, Cecilia Gunnarsson, Tommy Fornander, Bo Nordenskjöld, Lambert Skoog, Olle Stål and Agneta Jansson
  17β-hydroxysteroid dehydrogenase type 14 is a predictive marker for tamoxifen response in oestrogen receptor positive breast cancer
  PLoS ONE, 2012, 7(7), e40568.
   Fulltext  PDF  
 Web of Science® Times Cited: 1

Istvan Gati, Olof Danielsson, Cecilia Gunnarsson, Magnus Vrethem, Bo Häggqvist, Bengt-Arne Fredriksson and Anne-Marie Landtblom
  Letter: Bent Spine Syndrome: A Phenotype of Dysferlinopathy or a Symptomatic DYSF Gene Mutation Carrier
  European Neurology, 2012, 67(5), 300-302.
 Web of Science® Times Cited: 2

Meriam Aneq Åström, Christina Fluur, Malin Rehnberg, Peter Söderkvist, Jan Engvall, Eva Nylander and Cecilia Gunnarsson
  Novel plakophilin2 mutation. Three generation family with arrhythmogenic right ventricular cardiomyopathy
  Scandinavian Cardiovascular Journal, 2012, 46(2), 72-75.

Malin Rehnberg, Jon Jonasson and Cecilia Gunnarsson
  Letter: Novel L1CAM Splice Site Mutation in a Young Male With L1 Syndrome
  American Journal of Medical Genetics. Part A, 2011, 155A(2), 439-441.
 Web of Science® Times Cited: 1

Cecilia Gunnarsson and Cathrine Foyn Bruhn
  Molecular Characterization and Clinical Features of a Patient With an Interstitial Deletion of 3p25.3-p26.1
  AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2010, 152A(12), 3110-3114.
 Web of Science® Times Cited: 12

Kjerstin Ferm Widlund, Cecilia Gunnarsson, Karin Nordin and Mats G Hansson
  Pregnant women are satisfied with the information they receive about prenatal diagnosis, but are their decisions well informed?
  Acta obstetricia et gynecologica Scandinavica, 2009, 88(10), 1128-1132.
 Web of Science® Times Cited: 4

Cecilia Gunnarsson, Barbara Graffmann and Jon Jonasson
  Chromosome r(10)(p15.3q26.12) in a newborn child: case report.
  Molecular Cytogenetics, 2009, 2, 25.
   Fulltext  PDF  
 Web of Science® Times Cited: 3

Agneta Jansson, Lovisa Delander, Cecilia Gunnarsson, Tommy Fornander, Lambert Skoog, Bo Nordenskjöld and Olle Stål
  Ratio of 17HSD1 to 17HSD2 protein expression predicts the outcome of tamoxifen treatment in postmenopausal breast cancer patients.
  Clinical Cancer Research, 2009, 15(10), 3610-3616.
 Web of Science® Times Cited: 12

Cecilia Gunnarsson, Piiha-Lotta Jerevall, Karl Hammar, Birgit Olsson, Bo Nordenskjöld, Agneta Jansson and Olle Stål
  Amplification of HSD17B1 has prognostic significance in postmenopausal breast cancer
  Breast Cancer Research and Treatment, 2008, 108(1), 35-41.
 Web of Science® Times Cited: 18

Agneta Jansson, Jonas Carlsson, Anette Olsson, Petter Storm, Sara Margolin, Cecilia Gunnarsson, Marie Stenmark Askmalm, Annika Lindblom, Bengt Persson and Olle Stål
  A new polymorphism in the coding region of exon four in HSD17B2 in relation to risk of sporadic and hereditary breast cancer
  Breast Cancer Research and Treatment, 2007, 106(1), 57-64.
 Web of Science® Times Cited: 6

Agneta Jansson, Cecilia Gunnarsson and Olle Stål
  Proliferative responses to altered 17β-hydroxysteroid dehydrogenase (17HSD) type 2 expression in human breast cancer cells are dependent on endogenous expression of 17HSD type 1 and the oestradiol receptors
  Endocrine-Related Cancer, 2006, 13(3), 875-884.
 Web of Science® Times Cited: 13

Agneta Jansson, Cecilia Gunnarsson, Maja Cohen, Tove Sivik and Olle Stål
  17β-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer
  Cancer Research, 2006, 66(23), 11471-11477.
 Web of Science® Times Cited: 32

Cecilia Gunnarsson, Agneta Jansson, Birgitta Holmlund, Lilianne Ferraud, Bo Nordenskjöld, Lars Erik Rutqvist, Lambert Skoog and Olle Stål
  Expression of COX-2 and steroid converting enzymes in breast cancer
  Oncology Reports, 2006, 16(2), 219-224.
 Web of Science® Times Cited: 7

Cecilia Gunnarsson, Eva Hellqvist and Olle Stål
  17β-hydroxysteroid dehydrogenases involved in local oestrogen synthesis have prognostic significance in breast cancer
  British Journal of Cancer, 2005, 92(3), 547-552.
 Web of Science® Times Cited: 54

Cecilia Gunnarsson, Marie Ahnström, Kristina Kirschner, Birgit Olsson, Bo Nordenskjöld, Lars Erik Rutqvist, Lambert Skoog and Olle Stål
  Amplification of HSD17B1 and ERBB2 in primary breast cancer
  Oncogene, 2003, 22(1), 34-40.
 Web of Science® Times Cited: 53

Miodrag Palfi and Cecilia Gunnarsson
  The frequency of anti-C + anti-G in the absence of anti-D in alloimmunized pregnancies
  Transfusion Medicine, 2001, 11(3), 207-210.
 Web of Science® Times Cited: 7

Cecilia Gunnarsson, Birgit Olsson, Olle Stål and Lars-Gunnar Arnesson
  Abnormal expression of 17β-hydroxysteroid dehydrogenases in breast cancer predicts late recurrence
  Cancer Research, 2001, 61(23), 8448-8451.
 Web of Science® Times Cited: 72

Richard Lindgren, Cecilia Gunnarsson, Anna Jakobsson and Mats Hammar
  Hypersecretion of ovarian androgens may be gonadotrophin dependent many years after menopause
  Maturitas, 2000, 34(1), 43-46.
 Web of Science® Times Cited: 5

Ph.D. Theses

Cecilia Gunnarsson
  Steroid converting enzymes in breast cancer
  2005.


* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.